Benson Relaxation Technique and Stress in Pregnancy

NCT ID: NCT06870214

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-15

Study Completion Date

2025-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the effect of the Benson Relaxation Technique applied to pregnant women on their fear of birth, anxiety and stress levels.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to determine the effect of the Benson Relaxation Technique applied to pregnant women on their fear of birth, anxiety and stress levels.

Hypotheses ; H0-1: Benson relaxation technique applied to pregnant women has an effect on childbirth.

H1-1: Benson relaxation technique applied to pregnant women has no effect on childbirth.

H0-2: Benson relaxation technique applied to pregnant women has no effect on anxiety.

H1-2: Benson relaxation technique applied to pregnant women has an effect on anxiety.

H0-3: Benson relaxation technique applied to pregnant women and their partners has no effect on stress.

H1-3: Benson relaxation technique applied to pregnant women and their partners has an effect on stress The study will be conducted on two different groups. The application will be a 1-hour Benson relaxation technique applied to pregnant women in the third trimester every week for 4 weeks. Participants will be asked to do relaxation exercises twice a day, morning and evening, for 10 to 15 minutes for 1 month. A phone number that patients can call with questions will also be provided. In addition, the researcher will call the women in the intervention group every week to follow up on the relaxation process and answer questions.

After the women are evaluated in terms of eligibility criteria for the study, information about the study will be provided to the women who are eligible and written informed consent will be obtained from the women who accept. The random distribution of the women to the study groups will be carried out using the Block Randomization method. The following applications will be applied to the groups.

The researcher will contact the experimental group by phone. The application will end after 4 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Stress Relation, Interpersonal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

relaxation group

They will be interviewed according to the inclusion criteria and exclusion criteria, and they will be informed about the study and their consent will be obtained, the participant information form and depression form will be filled, a pre-test will be performed and the communication will be completed. Their numbers will be taken.

The intervention group will be given a 1-hour Benson relaxation technique every week for 4 weeks. Participants will be asked to do relaxation exercises for 10 to 15 minutes twice a day, in the morning and evening, for 1 month. A phone number will be provided for patients to call if they have questions. In addition, the researcher will call the women in the intervention group every week to follow up on the relaxation process and answer questions.

The researcher will contact the experimental group by phone. He/she will introduce himself/herself and final tests will be conducted after 4 weeks.

Group Type EXPERIMENTAL

relaxation

Intervention Type OTHER

Women in the 3rd trimester will receive routine care only.

control group

\*\*"Routine nursing care will be provided."\*\*

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

relaxation

Women in the 3rd trimester will receive routine care only.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

control group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who are in their 28th-38th weeks of pregnancy,
* People with mental illness,
* People who have Anxiety disorder,
* People with hearing loss;
* People who have no experience of using relaxation methods in the past,
* People who have not used herbal or medical sedatives

Exclusion Criteria

* Those who do not want to participate in the intervention,
* Those who have a termination of pregnancy during the intervention,
* Those who have a risky pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ondokuz Mayıs University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sümeyye BAL

Lecturer Ph. D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ondokuz Mayis University

Samsun, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sümeyye BAL, Ph.D

Role: CONTACT

05434276696

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-930

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.